NLRP3 and early-onset autosomal dominant Alzheimer disease: Emerging evidence suggests that NLRP3 activation is involved in inflammatory responses, antimicrobial responses, and various human diseases, including autoimmune inflammatory disease, Alzheimer’s disease, atherosclerosis, and type 2 diabetes [20].